Dynatronics Stock Price, News & Analysis (NASDAQ:DYNT)

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DYNT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DYNT, but not buy additional shares or sell existing shares.
View DYNT analyst ratings or view top-rated stocks.

1 brokers have issued 1 year price targets for Dynatronics' stock. Their DYNT share price targets range from $3.80 to $3.80. On average, they expect the company's stock price to reach $3.80 in the next year. This suggests a possible upside of 555.4% from the stock's current price.
View analysts price targets for DYNT or view top-rated stocks among Wall Street analysts.

Dynatronics' stock was trading at $1.9505 at the start of the year. Since then, DYNT shares have decreased by 70.3% and is now trading at $0.5798.
View the best growth stocks for 2023 here.

Dynatronics saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 57,800 shares, an increase of 549.4% from the October 31st total of 8,900 shares. Based on an average daily trading volume, of 25,300 shares, the days-to-cover ratio is currently 2.3 days. Approximately 1.8% of the shares of the company are short sold.
View Dynatronics' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our DYNT earnings forecast.

Dynatronics Co. (NASDAQ:DYNT) posted its quarterly earnings data on Thursday, September, 28th. The medical equipment provider reported ($0.63) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by $0.29. The medical equipment provider had revenue of $8.44 million for the quarter, compared to the consensus estimate of $8.04 million. Dynatronics had a negative net margin of 12.66% and a negative trailing twelve-month return on equity of 46.68%. During the same period in the prior year, the business earned ($0.50) earnings per share.

Dynatronics shares reverse split before market open on Tuesday, January 31st 2023. The 1-5 reverse split was announced on Tuesday, January 31st 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 31st 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Dynatronics updated its FY 2024 earnings guidance on Thursday, September, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $34.00 million-$37.00 million, compared to the consensus revenue estimate of $35.50 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Dynatronics investors own include Biocept (BIOC), Nuwellis (CHFS), Heat Biologics (HTBX), Bionano Genomics (BNGO), iBio (IBIO), Alto Ingredients (PEIX), Sorrento Therapeutics (SRNE), Palatin Technologies (PTN) and Electrameccanica Vehicles (SOLO).

Shares of DYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.